Home/Filings/5/0000899243-19-003415
5//SEC Filing

Essex Woodlands IX, LLC 5

Accession 0000899243-19-003415

CIK 0001314102other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 2:31 PM ET

Size

13.2 KB

Accession

0000899243-19-003415

Insider Transaction Report

Form 5
Period: 2018-12-31
Transactions
  • Conversion

    Common Stock, $0.001 par value

    2018-09-28$1.43/sh+652,244$932,70941,903,956 total(indirect: EW Healthcare Partners-A L.P.)
  • Conversion

    Common Stock, $0.001 par value

    2018-09-28$1.43/sh+16,211,822$23,182,90541,903,956 total
Transactions
  • Conversion

    Common Stock, $0.001 par value

    2018-09-28$1.43/sh+652,244$932,70941,903,956 total(indirect: EW Healthcare Partners-A L.P.)
  • Conversion

    Common Stock, $0.001 par value

    2018-09-28$1.43/sh+16,211,822$23,182,90541,903,956 total
Transactions
  • Conversion

    Common Stock, $0.001 par value

    2018-09-28$1.43/sh+16,211,822$23,182,90541,903,956 total
  • Conversion

    Common Stock, $0.001 par value

    2018-09-28$1.43/sh+652,244$932,70941,903,956 total(indirect: EW Healthcare Partners-A L.P.)
Transactions
  • Conversion

    Common Stock, $0.001 par value

    2018-09-28$1.43/sh+16,211,822$23,182,90541,903,956 total
  • Conversion

    Common Stock, $0.001 par value

    2018-09-28$1.43/sh+652,244$932,70941,903,956 total(indirect: EW Healthcare Partners-A L.P.)
Footnotes (1)
  • [F1]Includes 40,283,255 shares held by EW Healthcare Partners L.P. ("EWHP") and 1,620,701 shares held by EW Healthcare Partners-A L.P. ("EWHP-A"). Essex Woodlands Fund IX-GP, L.P. ("Fund IX-GP") is the general partner of EWHP and EWHP-A, respectively. Essex Woodlands IX, LLC (the "General Partner") is the general partner of Fund IX-GP. The General Partner holds sole voting and dispositive power over the shares held by EWHP and EWHP-A. The managers of the General Partner are Martin P. Sutter, R. Scott Barry, Ronald Eastman (also a member of the Issuer's board of directors) and Petri Vainio (collectively, the "Managers"), and may exercise voting and investment control over the shares only by the majority action of the Managers.

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001652286

Filing Metadata

Form type
5
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 2:31 PM ET
Size
13.2 KB